We believe that fingerprinting the immune system can be a game-changer when it comes to improving the surgical journey for millions of patients. Combining innovative technologies with artificial intelligence, our multidisciplinary team of clinicians, engineers and scientists is focused on holistically improving the standard-of-care. Predicting the risk for complications before surgery is critical to allow personalization of pre-operative clinical interventions, surgical decision-making and improvement of surgical outcomes. 30% of major surgeries result in complications within 30 days postoperatively, such as infection or pneumonia, and even death. Surge is grounded in more than seven years of clinical, basic science, and translational research led by our team at Stanford University. Our test combines single-cell assessment of the immune system before surgery with clinical data available through Electronic Health Records (EHR) using a proprietary machine learning algorithm. Individual immune systems are comprehensively assessed from a single blood sample obtained before surgery and analyzed using mass cytometry. Our method allows us to mimic surgical trauma in a test tube with a small amount of blood containing millions of immune cells before surgery. We use this technique to understand exactly how every immune cell in your body is responding to the trauma to precisely predict postoperative outcomes.
Employees: 1-10
Total raised: $10.69M
Founded date: 2021
Investors 1
Date | Name | Website |
28.09.2022 | Hardware C... | hcvc.co |
Funding Rounds 2
Date | Series | Amount | Investors |
28.03.2024 | - | $8.09M | - |
26.09.2022 | - | $2.6M | - |
Persons 2
Date | First Name | Last Name | Title | Location | |||
- | Julien | Hédou | - | linkedin.c... | - | - | - |
- | Grégoire | Bellan | - | linkedin.c... | - | g*********... | - |
Mentions in press and media 7
Date | Title | Description | Source |
28.03.2024 | Surge Closes €7.5M Funding Round | Surge, a Paris, France-based company which specializes in high-dimensional immune system analysis co... | finsmes.co... |
28.03.2024 | Paris-based Surge gets €7.5M to decrypt immune system and ac... | Read this article in: Paris-based Surge, a company specialised in high-dimensional immune system ana... | siliconcan... |
26.09.2022 | Surge raises $2.6M to predict surgery complications from a b... | The company also entered into an exclusive licensing agreement with Stanford There are nearly 6.1 mi... | vator.tv/n... |
26.09.2022 | Surge Raises €2.5M in Funding | Surge, a San Francisco, CA- and Paris, France-based biotech and medical AI company, raised €2.5M in ... | finsmes.co... |
22.09.2022 | Surge Raises $2.6M for Blood Test to Predict Post-Surgery Co... | What You Should Know: | hitconsult... |
22.09.2022 | Making surgeries safer, French biotech Surge raises $2.6 mil... | French biotech and medical AI platform Surge has raised $2.6 million in funding to decode a patient’... | tech.eu/20... |
- | Surge | “PreCyte integrates high-resolution immune system exploration with predictive information to develop... | fastfounde... |